Central DuPage Hospital Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2009
NCT01184196
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Central DuPage Hospital

Active Ingredients

Drugs in Phase 4 Trials (2)

chlorhexidine (hibitane) (1 trial)

povidone-iodine (betadine) (1 trial)

Drugs in Other Trials (2)

lavender (2 trials)

peppermint extract (1 trial)

Indications

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4